Euglycemic Diabetic Ketoacidosis Related to SGLT2 Inhibitor Use in a Patient With Cobalamin C Deficiency and Diabetes

A 24-year-old woman with cobalamin C deficiency (CblCD), autoimmune thyroiditis, and recently diagnosed diabetes mellitus presented with weight loss, emesis, and abdominal pain. She had been placed on sodium-glucose cotransporter inhibitor (SGLT2i) therapy because of metformin intolerance, with the...

Full description

Bibliographic Details

Published in:	Annals of Internal Medicine: Clinical Cases
Main Authors:	Camilia Kamoun, Jaclyn Tamaroff, Sanmati Cuddapah, Marc Yudkoff, Shana McCormack, Jessica I. Gold
Format:	Article
Language:	English
Published:	American College of Physicians 2023-01-01
Online Access:	https://www.acpjournals.org/doi/10.7326/aimcc.2022.0346